Genflow Biosciences shares jump on AI partnership to accelerate drug discovery
2 Articles
2 Articles
Satio, Nanowear collab on AI-powered biomarkers in drug delivery
The SatioRx drug delivery device. [Screenshot taken from Satio demonstration video]Satio and Nanowear today announced that they partnered to advance patient-friendly, home-based diagnostic and therapeutic care. The collaboration aims to integrate Nanowear’s at-home AI-based nanotechnology biomarker diagnostic platform with Satio’s at-home blood draw diagnostics and drug delivery systems/patches. This would combine time-synchronous, in vivo and i…
Genflow Biosciences shares jump on AI partnership to accelerate drug discovery
Shares in longevity-focused Genflow Biosciences jumped on Monday after the company outlined plans to to accelerate drug discovery through the use of an AI-powered platform. Genflow Biosciences, Europe’s sole publicly listed longevity company, has established a strategic alliance with American AI specialists Heureka Labs, providing access to Heureka’s sophisticated artificial intelligence platform. Developed as a […] The post Genflow Biosciences …
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage